嘉和生物药业(开曼)控股有限公司(06998.HK)今日盘中股价大涨6.15%,报1.890港元/股,成为市场关注的焦点。这一涨幅主要受到公司与亿腾医药合并的利好消息所推动。
数据显示,早盘资金流向嘉和生物-B股票呈现净流入态势,其中资金流入5.0515万港元,流出4.6435万港元。这一资金面向好情况也从侧面为股价上涨提供了支撑。
10月7日,嘉和生物发布公告称,将通过合并方式收购亿腾医药,合并后的新公司预计更名为"亿腾嘉和"。亿腾医药是一家专注于自主研发创新药物的生物医药公司,旗下拥有多个商业化产品。此次合并意味着双方在生物制药领域的优势资源将实现整合,有助于提升新公司的市场竞争力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.